Back to
ROYAL BANK OF CANADA
BCTX4 quarters
Position history for
ROYAL BANK OF CANADA's holdings in BRIACELL THERAPEUTICS CORP
Yes. Royal Bank of Canada holds 289 shares of BCTX (Briacell Therapeutics), worth $1,000, as of its Q2 2026 13F filing. It increased the position by 189 shares (+189.0%) from Q1 2026. Royal Bank of Canada has held BCTX since Q3 2025, across 4 quarterly 13F filings.
Current Value
$1,000
Current Shares
289
Total Value Change
$0
Total Shares Change
+189
Quarter-by-Quarter History
Other major holders of BCTX: UBS Group AG, CITADEL ADVISORS LLC, HRT FINANCIAL LP, JANE STREET GROUP, LLC